Provider review
CLYR Health review
Bills on eight-week cycles while quoting the price per month.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$199 on eight-week cycles after a $149 first month
Visit CLYR HealthEight weeks recurs six and a half times a year, and the page does not say which charge lands when.
Price as published
CLYR Health
$199 on eight-week cycles after a $149 first month
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded, a 503A pharmacy, not named
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two things here are done well and one is genuinely confusing. Done well: the introductory rate and the standing rate are both on the page, so the step is visible before you start rather than at the second charge, and the inclusion list is specific enough to be useful — consultation, prescription, ongoing dose adjustments and priority shipping, all named rather than gestured at. The confusing part is the cadence. Billing runs on eight-week cycles and the figure is described per month, which are not the same unit, and nothing says whether the charge lands every eight weeks or monthly within a cycle. Eight weeks comes round six and a half times a year; twelve months come round twelve. Those produce materially different annual costs from the same number, and you cannot tell from the page which one you are being quoted. A second pricing tier exists at a considerably higher figure with no explanation of what puts somebody in it. The pharmacy class is referenced repeatedly; no milligram appears.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the first-month and standing rates both stated before starting
- You want ongoing dose adjustments named as part of what you are paying for
- You will ask how often the charge actually lands
Look elsewhere if
- You are budgeting annually — the cycle is eight weeks, not a month
- You want to know what puts you into the higher tier
- You want a dose behind the number
What it actually costs
Price as published
$199 on eight-week cycles after a $149 first month
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Billing runs on eight-week cycles while the figure is quoted per month — a period that is neither a month nor a quarter, recurring six and a half times a year. The site does not say which charge lands when, so the annual cost cannot be worked out. The introductory and standing rates are both published and the inclusion list is specific, which is more than most manage. A second plan level exists with no stated entry criterion.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Publishes the first-month rate and the standing rate together.
- Names what the fee covers, including ongoing dose adjustments.
- References the pharmacy class repeatedly and states cancellation terms.
Pharmacy, labs and oversight
CLYR Health says it uses a 503A pharmacy, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What CLYR Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedSays it uses a 503A pharmacy, but does not say which one.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Two things here are done well and one is genuinely confusing. Done well: the introductory rate and the standing rate are both on the page, so the step is visible before starting rather than at the second charge, and the inclusion list is specific enough to be useful — consultation, prescription, ongoing dose adjustments and shipping, all named. The confusing part is the cadence. Billing runs on eight-week cycles and the figure is described per month, which are not the same unit, and the page does not say whether the charge lands every eight weeks or monthly within a cycle. Eight weeks recurs six and a half times a year; twelve months recur twelve. Those produce materially different annual costs from the same number, and a reader cannot tell which they are being quoted. A second pricing tier exists at a higher figure with no explanation of what puts someone in it. The pharmacy class is referenced repeatedly; no milligram appears.
The honest cons
Billing runs on eight-week cycles while the figure is quoted per month.
- A second, higher tier exists with no stated criterion for entering it.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
CLYR Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way CLYR Health does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sesame Care
Wegovy pill from $149/mo + sub
Standard plan, self-directed low dose
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Where this sits
#349 of 548
Ordered with the companies that pay us first, and CLYR Health is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Willow
From $299/mo covering all four formats, none priced separately
- Vs median
- $124/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Willow review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.